A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant re... von Ljungman, Per, Bermudez, Arancha, Logan, Aaron C., Kharfan-Dabaja, Mohamed A., Chevallier, Patrice, Martino, Rodrigo, Wulf, Gerald, Selleslag, Dominik, Kakihana, Kazuhiko, Langston, Amelia, Lee, Dong-Gun, Solano, Carlos, Okamoto, Shinichiro, Smith, Larry R., Boeckh, Michael, Wingard, John R., Cywin, Beth, Fredericks, Christine, Lademacher, Christopher, Wang, Xuegong, Young, James, Maertens, Johan

Volltext

Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years von Chichili, Gurunadh R., Smulders, Ronald, Santos, Vicki, Cywin, Beth, Kovanda, Laura, Van Sant, Charles, Malinoski, Frank, Sebastian, Shite, Siber, George, Malley, Richard

Volltext

Corrigendum to “Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years” [Vaccine 40 (2022) 4190–419... von Chichili, Gurunadh R., Smulders, Ronald, Santos, Vicki, Cywin, Beth, Kovanda, Laura, Van Sant, Charles, Malinoski, Frank, Sebastian, Shite, Siber, George, Malley, Richard

Volltext

Corrigendum to "Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years" Vaccine 40 (2022) 4190-4198 von Chichili, Gurunadh R, Smulders, Ronald, Santos, Vicki, Cywin, Beth, Kovanda, Laura, Van Sant, Charles, Malinoski, Frank, Sebastian, Shite, Siber, George, Malley, Richard

Volltext

1242. Safety and Immunogenicity of Novel 24-Valent Pneumococcal Vaccine in Healthy Adults von Chichili, Gurunadh, Smulders, Ronald, Santos, Vicki, Cywin, Beth, Kovanda, Laura, Malinoski, Frank J, Sebastian, Shite, Siber, George R, Malley, Rick

Volltext

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant re... von Ljungman, Per, Bermudez, Arancha, Logan, Aaron C, Kharfan-Dabaja, Mohamed A, Chevallier, Patrice, Martino, Rodrigo, Wulf, Gerald, Selleslag, Dominik, Kakihana, Kazuhiko, Langston, Amelia, Lee, Dong-Gun, Solano, Carlos, Okamoto, Shinichiro, Smith, Larry R, Boeckh, Michael, Wingard, John R, Cywin, Beth, Fredericks, Christine, Lademacher, Christopher, Wang, Xuegong, Young, James, Maertens, Johan

Volltext

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant re... von Ljungman, Per, Bermúdez, Arancha, Logan, Aaron C, Kharfan-Dabaja, Mohamed A, Chevallier, Patrice, Martino Bofarull, Rodrigo, Wulf, Gerald, Selleslag, Dominik, Kakihana, Kazuhiko, Langston, Amelia, Lee, Dong-Gun, Solano, Carlos, Okamoto, Shinichiro, Smith, Larry R, Boeckh, Michael, Wingard, John Reid, Cywin, Beth, Fredericks, Christine, Lademacher, Christopher, Wang, Xuegong, Young, James, Maertens, Johan

Volltext bestellen

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant re... von Ljungman, Per, Bermúdez, Arancha, Logan, Aaron C, Kharfan-Dabaja, Mohamed A, Chevallier, Patrice, Martino Bofarull, Rodrigo, Wulf, Gerald, Selleslag, Dominik, Kakihana, Kazuhiko, Langston, Amelia, Lee, Dong-Gun, Solano, Carlos, Okamoto, Shinichiro, Smith, Larry R, Boeckh, Michael, Wingard, John Reid, Cywin, Beth, Fredericks, Christine, Lademacher, Christopher, Wang, Xuegong, Young, James, Maertens, Johan

Volltext bestellen